Lab
Etx Diagnostics LLC
Etx Diagnostics LLC was paid $58K by Medicaid between Jun 2023 and Nov 2024, across 70 billing codes. Its largest line is 81317, — 11% of everything it billed.
33Billing provider infoETX DIAGNOSTICS LLC
STAFFORD, TX 77477
STAFFORD, TX 77477
33aNPI1760189898assigned 02/09/2023
33bProvider typeClinical Medical Laboratory
28Total paid$58K
24GClaims13,980
24DCodes billed70
24AFirst – last monthJun 2023 – Nov 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Texas
Rank by total paid#176 of 436
Median peer was paid$17K
This provider vs. median3.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2023 | 42 | $349.10 | |
| 2024incomplete | 13,938 | $58K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 81317 | 11% | 268 | 267 | $6K | |
| 81238 | 9.9% | 268 | 267 | $6K | |
| 81298 | 7.7% | 269 | 268 | $5K | |
| 81321 | 6.5% | 507 | 506 | $4K | |
| 81307 | 5.7% | 131 | 130 | $3K | |
| 81223 | 5.1% | 108 | 107 | $3K | |
| 81249 | 5.0% | 124 | 123 | $3K | |
| 81191 | 4.7% | 704 | 703 | $3K | |
| 81339 | 3.6% | 474 | 473 | $2K | |
| 81279 | 3.1% | 273 | 272 | $2K | |
| 81324 | 2.5% | 33 | 33 | $1K | |
| 81311 | 2.4% | 124 | 123 | $1K |
58 more codes
| 81320 | 2.4% | 160 | $1K | |
| 87483 | 2.1% | 354 | $1K | |
| 81345 | 2.0% | 321 | $1K | |
| 81216 | 2.0% | 319 | $1K | |
| 81335 | 1.9% | 321 | $1K | |
| 81334 | 1.8% | 102 | $1K | |
| 81185 | 1.4% | 44 | $829.34 | |
| 81309 | 1.4% | 283 | $807.99 | |
| 81333 | 1.2% | 125 | $671.30 | |
| 81250 | 1.1% | 467 | $657.16 | |
| 81233 | <1% | 102 | $555.68 | |
| 81305 | <1% | 102 | $555.68 | |
| 81260 | <1% | 470 | $441.64 | |
| 87631 | <1% | 354 | $419.34 | |
| 81192 | <1% | 230 | $406.32 | |
| 81210 | <1% | 101 | $308.72 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 328 | $281.64 |
| 81189 | <1% | 44 | $269.33 | |
| 81178 | <1% | 228 | $268.52 | |
| 81177 | <1% | 228 | $268.52 | |
| 81312 | <1% | 228 | $268.52 | |
| 81329 | <1% | 72 | $268.52 | |
| 81188 | <1% | 228 | $268.52 | |
| 81183 | <1% | 228 | $268.52 | |
| 81171 | <1% | 72 | $268.52 | |
| 81343 | <1% | 228 | $268.52 | |
| 81179 | <1% | 228 | $268.52 | |
| 81284 | <1% | 228 | $268.52 | |
| 81180 | <1% | 228 | $268.52 | |
| 81181 | <1% | 228 | $268.52 | |
| 81344 | <1% | 229 | $268.52 | |
| 81182 | <1% | 228 | $268.52 | |
| 81271 | <1% | 228 | $268.52 | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 21 | $249.92 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 734 | $206.34 |
| 81209 | <1% | 131 | $192.60 | |
| 81256 | <1% | 102 | $192.15 | |
| 81242 | <1% | 131 | $179.45 | |
| 81243 | <1% | 46 | $111.80 | |
| 87498 | <1% | 354 | $103.17 | |
| 87640 | <1% | 361 | $103.17 | |
| 87486 | <1% | 354 | $103.17 | |
| 87581 | <1% | 354 | $103.17 | |
| 87541 | <1% | 354 | $103.17 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 21 | $99.18 |
| 81251 | <1% | 33 | $92.60 | |
| 81232 | 0% | 39 | $0.00 | |
| 87652 | 0% | 23 | $0.00 | |
| 87150 | 0% | 25 | $0.00 | |
| 81175 | 0% | 19 | $0.00 | |
| 87481 | 0% | 30 | $0.00 | |
| 81241 | 0% | 13 | $0.00 | |
| 87641 | 0% | 23 | $0.00 | |
| 87496 | 0% | 114 | $0.00 | |
| 87500 | 0% | 23 | $0.00 | |
| 81236 | 0% | 19 | $0.00 | |
| 81351 | 0% | 24 | $0.00 | |
| 81327 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialAVERY, KAREN (DIRECTOR OF BILLING)
| Provider | Location | Paid |
|---|---|---|
| Reliance Diagnostics LLC | Miami, FL | $846K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.